Silvia Ulrich, Prof. Dr.

Trials

Studies that name Silvia Ulrich, Prof. Dr. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:24 UTC. Open this list on ClinicalTrials.gov

• Ph2/Ph3
  NCT07824674 · The Effect of Additive On-Demand Sildenafil vs. Dextrose Candy on Maximum Exercise Capacity in Pulmonary Arterial Hypertension

  Silvia Ulrich · recruiting · Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) · principal investigator
• N/A
  NCT07777445 · Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD)

  Silvia Ulrich Somaini · recruiting · Pulmonary Vascular Disease, Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Pulmonary Arterial Hypertension (PAH) · principal investigator
• N/A
  NCT07777367 · Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases

  Silvia Ulrich Somaini · recruiting · Pulmonary Vascular Disease, Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Pulmonary Arterial Hypertension (PAH) · principal investigator
• Ph4
  NCT06498505 · HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men

  University of Zurich · completed · High Altitude · study chair
• N/A
  NCT06489756 · Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)

  University of Zurich · completed · High Altitude Pulmonary Hypertension · principal investigator
• N/A
  NCT06489743 · Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)

  University of Zurich · completed · High Altitude Pulmonary Hypertension · principal investigator
• N/A
  NCT06489704 · High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)

  University of Zurich · completed · High Altitude Pulmonary Hypertension · principal investigator
• N/A
  NCT06489691 · High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), 6MWT Assessed at High Altitude (3200m) vs Low Altitude (760m)

  University of Zurich · completed · High Altitude Pulmonary Hypertension · principal investigator
• N/A
  NCT06489717 · High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m)

  University of Zurich · completed · High Altitude Pulmonary Hypertension · principal investigator
• N/A
  NCT06489730 · HAPH Registry: Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.

  University of Zurich · unknown · High Altitude Pulmonary Hypertension, Sleep Apnea · principal investigator
• N/A
  NCT06385301 · Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases

  University of Zurich · completed · Lung Disease Chronic, Lung Diseases, Interstitial, Lung Diseases, Obstructive · principal investigator
• N/A
  NCT06384534 · Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD)

  University of Zurich · completed · Pulmonary Vascular Disorder, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension · principal investigator
• N/A
  NCT06084559 · HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)

  University of Zurich · unknown · Pulmonary Vascular Disorder, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension · principal investigator
• N/A
  NCT06072417 · HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)

  University of Zurich · unknown · Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension · principal investigator
• N/A
  NCT06003244 · High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

  University of Zurich · unknown · Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension · principal investigator
• N/A
  NCT05996302 · HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)

  University of Zurich · unknown · Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension · principal investigator
• N/A
  NCT05610631 · Pulmonary Hypertension Registry Switzerland

  University of Zurich · recruiting · Pulmonary Hypertension · principal investigator
• N/A
  NCT04715113 · Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary Hypertension

  University of Zurich · completed · Hypertension, Pulmonary · principal investigator
• N/A
  NCT04706546 · Hemodynamic Effects During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil

  University of Zurich · completed · Hypertension, Pulmonary · principal investigator
• N/A
  NCT04704440 · Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without Sildenafil

  University of Zurich · completed · Hypertension, Pulmonary · principal investigator
• N/A
  NCT04697875 · Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension

  University of Zurich · completed · Hypertension, Pulmonary · principal investigator
• N/A
  NCT04697862 · Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil

  University of Zurich · completed · Hypertension, Pulmonary · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.